Gold Sponsors

ECA Medical


Kapstone Medical

Lincotek Medical



Supporting Organizations

Bartlett Area Chamber



Medtech Intelligence

Memphis Moves

Silver Sponsors

Able Medical Devices

AIP Precision Machining

Carpenter Technology

Elos Medtech

Gauthier Biomedical


Mach Medical




Tegra Medical

Teleflex Medical OEM

Titanium Industries


Viant Medical

Bronze Sponsors

Able Electropolishing

Autocam Medical

Cretex Medical

Life Science Outsourcing






Y&W Technologies

Mike Carroll

Mike Carroll, Founder/President, Focus Medical Design and Development LLC
Mike Carroll has worked in medical device research and development for over 30 years. He has experience in applied research, product development, and testing and analysis of products ranging from bone ingrowth coatings and composite bone graft substitutes to implant and instrument systems for joint replacement and fracture repair. He has led teams involved in biomaterials and biomechanics research as well as implant and instrument design and development, which have resulted in the commercialization of many products. Carroll has extensive experience in mechanical testing of implants, materials, and instrument systems to ASTM and ISO testing standards, as well as the development and execution of customized testing protocols where no standards currently exist. He co-founded Focus Medical Design and Development in 2016, a company that provides mechanical testing and finite element analysis, as well as design and development services, to the medical device industry. Carroll received a BS in Mechanical Engineering from Memphis State University in 1989.

Troy D. Drewry

Troy D. Drewry; Professor of Practice—Biomedical Engineering; Operations Manager—Center for Diagnostics, Design, Devices, and Biomechanics; The University of Mississippi
Troy D. Drewry is currently a Professor of Practice in the Biomedical Engineering Department and the Operations Manager for the Center of Diagnostics, Design, Devices, and Biomechanics at the University of Mississippi in Oxford. He is also the founder and principal engineer of Ragin Cajun Consulting LLC—a medical device design and development consulting firm in Memphis, TN. He has over 25 years of industry experience in the field of medical device design and development and started out as an entry level engineer and rose up to executive management positions at Medtronic Spinal and Biologics, Active Implants, and Paradigm Spine. He is a named inventor of over 60 U.S. issued patents and 30 international patents. He holds a BS Degree in Mechanical Engineering from the University of Southwestern Louisiana, MS Degree in Biomedical Engineering from University of Memphis, and an MS Degree in Engineering Management from Christian Brothers University.

Patrick Fisher

Patrick Fisher, VP & GM—Foot & Ankle, Stryker
Patrick Fisher is the vice president and general manager for Stryker’s Foot and Ankle Business Unit. The Foot and Ankle Business Unit resides within the larger Trauma and Extremities organization inside Stryker’s Orthopaedics Division. Fisher attended Rhodes College (1996; BA in International Studies) and completed his MBA in International Business from the University of Memphis in 2000. He began his career with Smith and Nephew in several roles, including an internship in Mexico, and several consulting roles within the HR team and product marketing. In 2002, he made the move to Wright Medical where he held several key roles in hip and knee marketing. Then in 2010, he moved to Denver with his family as the west region sales leader. Fisher returned to Memphis in 2012 as the VP of Sales for Wright’s newly formed Foot and Ankle and Biologics business and was then promoted to president of Lower Extremities and Biologics four years later. Today, he continues in his role as the leader of Stryker’s Foot and Ankle U.S. Business since the close of the Wright Medical acquisition by Stryker in November 2020. He is an ardent supporter of all things Memphis, and most recently joined the Board of Directors for the Greater Memphis Medical Device Council. Fisher resides in East Memphis with his wife and three children and loves the Grizzlies and Tigers.

Lane Hale

Lane Hale, President & CEO, ECA Medical
Lane Hale is president and CEO of ECA Medical. ECA is the premier, single-procedure instrument and surgery-ready procedural kit developer and manufacturer for the medical device industry. ECA is a proven partner demonstrated by its 43 years in the cardio and neuro sectors designing and manufacturing single-procedure instruments to secure medical implants. The company’s core technology and knowledge have been effectively applied to the orthopedics sector. ECA offers a portfolio of single-procedure instruments, including precision torque limiters that are hand or power operated, and develops and manufactures implant-specific, surgery-ready instrument and implant systems. These systems allow implant companies to deliver instruments and implants more efficiently to hospitals and outpatient surgery centers throughout the world. Hale has held leadership positions in medtech, serving in operations, business development, and product development roles during his 20-plus year career in the medical device industry. Earlier in his career, Hale worked in investment banking at Goldman Sacks and the business consulting industry. He holds a BA and MBA from Brigham Young University.

Dan Justin

Dan Justin, CEO, Nanovation Partners
Dan Justin has thirty-five years of experience in medical implant development and commercialization. He has led teams that have brought over 100 new orthopedic, trauma, and spinal implant products to worldwide markets over his career. Justin co-founded and managed five start-up medical device companies. The most recent, Engage Surgical, was acquired by Smith + Nephew in January of 2022. He is currently the CEO of Nanovation Partners, and a consultant to the medical device industry. He is a registered U.S. Patent Agent and inventor on over 165 granted U.S. patents. He holds a BSE and MS in Mechanical Engineering from the University of Central Florida.

Mehdi Kazemzadeh-Narbat

Mehdi Kazemzadeh-Narbat, PhD, PMP, CQA; Associate Director, Regulatory Affairs; MCRA LLC
Dr. Kazemzadeh-Narbat was the former U.S. Food and Drug Administration (FDA) lead reviewer and acting team lead in the Center for Devices and Radiological Health (CDRH) as a pre-market and post-market lead reviewer of Orthopedic (OHT6) and Dental (OHT1) devices. He has extensive knowledge of medical device regulatory science and pathways to drive technologies from conception to market. Dr. Kazemzadeh-Narbat is a biomedical engineer with five years of FDA experience in medical device regulation and is a consultant and subject matter expert for biocompatibility, animal study, and antimicrobial associated devices. At FDA, Dr. Kazemzadeh-Narbat published multiple regulatory science papers and developed two guidance documents on bone void fillers. Before FDA, Dr. Kazemzadeh-Narbat was a research engineer supervisor at Cook Biotech Inc. Prior to that, he was a postdoctoral fellow at Harvard-MIT Division of Health Sciences and Technology, and postdoctoral fellow at Dalhousie University. Dr. Kazemzadeh-Narbat received his Ph.D. in biomedical engineering from the University of British Columbia, Vancouver in 2012.

Meredith L. May

Meredith L. May, MS, RAC, CQA, Director of Consulting, Empirical Technologies Corp.
Meredith May, a biomedical engineer, brings decades of orthopedic implant industry experience in manufacturing, design, regulatory, and quality to your project team. She has been successful at bringing orthopedic products to market on shoestring budgets with condensed timelines, so she understands the needs of orthopedic implant companies. May has a master’s degree in entrepreneurship and brings an even greater business knowledge specific to small- to medium-sized companies. She is a regulatory expert who’s worked on all aspects of bringing a medical device to market, including regulatory affairs, quality assurance, process development, product development, quality systems, risk assessment, validation, verification, and CAPA.

Brian R. McLaughlin

Brian R. McLaughlin, Founder & CEO, Amplify Inc.
Brian McLaughlin is the president and founder of Amplify Additive, a leading Additive Manufacturing supplier focused 100% on 3D printed Titanium Orthopedic Implants. Prior to Amplify, Brian was the VP of Engineering, Quality & Operations for Additive Orthopedics, while also being the original founder with patents on 3D printed Titanium implants for Foot & Ankle applications. McLaughlin gained valuable experience 3D printing Orthopedic Implants when he was the Additive Manufacturing Business Unit manager for DiSanto Technology, an Arcam company, which was acquired by GE Additive. DTI was a contract manufacturer for orthopedic implants and McLaughlin’s team was focused on leveraging EBM for the design and manufacturing of 3D printed titanium implants for OEM clients. He managed six Arcam Q10 EBM machines supporting over 40 clients. McLaughlin also worked for Orchid Orthopedic Solutions, the second largest CMO in the U.S. for orthopedics. In addition to engineering and manufacturing experience, he has experience as an orthopedic sales representative, selling extremity implants and gaining valuable clinical experience in the OR working with clinicians and administration. McLaughlin also has extensive design experience across various other industries and has been using 3D printing his entire career.

Christopher Oleksy

Christopher Oleksy, Co-Founder/CEO, Next Life Medical; CEO, Emergent Respiratory
Christopher Oleksy is co-founder and CEO of Next Life Medical. He is also currently the acting CEO of Emergent Respiratory—an emergency CPAP company acquired by Next Life Medical. Emergent is known for its CPAP device, the PortO2Vent CPAPos. Previously, Oleksy was president of Integra Biotechnical (now Providien Medical), a vertically integrated medical device contract manufacturing company providing a full range of supply chain services such as injection molding, assembly, packaging, and sterilization management for Class II and Class III devices. He also served as president of ATEK Medical (acquired by Vention Medical in 2011). Oleksy has also held several executive supply chain management positions within Medtronic plc and Dow Corning Corporation. Oleksy is known as a supply chain pioneer and thought leader who has developed, authored, presented, and, successfully implemented customer-focused value chain thinking for over 30 years. He was one of the founding authors of the global industry ANSI standard, Supply Chain Operations Reference (SCOR) Model facilitated by PRTM and AMR.

William Pratt

William Pratt, VP Operations and Director of Creative Design, Kinamed Inc.
William Pratt has worked in the medical device industry for over 30 years in a variety of manufacturing, operations, and design roles. He holds several U.S. and international patents related to surgical implants and instruments, many of which have been successfully commercialized. His design activities range from direct product development and collaboration to manufacturing process and equipment development. Pratt’s board memberships include the Southern California Biomedical Council and Ventura County Workforce Development Board. He advises biotechnology programs at Ventura and Moorpark Colleges, and he is an industry advisor to the Community College Consortium for Bioscience Credentials and the Bioengineering Departments of UCLA and UC Riverside.

Christine Scifert

Christine Scifert, MS, MEM; Partner; MRC Global
As founder and partner, Scifert’s vision has made MRC Global a leading regulatory and quality systems consulting firm, highly respected throughout the medical device industry. Her extensive regulatory background has made her a sought-after resource by established medical device manufacturers and product development teams, as well as new device starts-ups and investors evaluating market potential. Leveraging her talent, clients are able to identify regulatory hurdles, develop a more realistic launch protocol, and expedite market entry while significantly reducing expenses and maximizing resources. Prior to MRC Global, Scifert spent 11 years as a consultant with MRC-X LLC and Memphis Regulatory Consulting, and 9 years at Medtronic Spinal and Biologics, directing the regulatory department of 22 people. As senior director, she set regulatory strategy, oversaw global submissions, and developed a design control process. Scifert interfaced directly with the FDA and notified bodies, overseeing the modification and implementation of all department procedures to maintain regulatory compliance while performing due diligence activities for potential acquisitions. She received a Bachelor of Science in Physics from Hamline University and a Master of Science in Biomedical Engineering from University of Iowa. She also completed a Master in Engineering Management from Christian Brothers University.

Scott Shankle

Scott Shankle, Vice President of Operations, MicroPort Orthopedics Inc.
Scott Shankle has been part of the MicroPort Orthopedics Inc. team since the inception of the company in January 2014 and is currently the vice president of Operations. Prior to the acquisition of Wright Medical Technology’s OrthoRecon Business by MicroPort, Shankle held various roles of increasing responsibility within Quality and Operations at Wright for 15 years. This experience cumulated with the role of senior director of global quality, which he held from 2011 through the acquisition in 2014. Shankle holds Bachelor’s and Master’s of Science degrees from the University of Memphis in Engineering Technology, focused in operations management, process improvement, and industrial statistics. He also served as adjunct professor at his alma mater from 2001 to 2007.

David Sharp

David Sharp, VP of Global Marketing, Catalyst Orthoscience
David Sharp has worked in the medical device industry for over 27 years in a variety of marketing, strategy, business development, communications, and branding leadership positions. He began his career in 1994 with Danek Medical in several roles, starting in the distribution department before moving to marketing and sales training roles. In 2004, he made the move to Smith & Nephew to work on the knee franchise in several roles in both upstream and downstream marketing functions. In late 2006, he returned to the spine market with Medtronic Spinal & Biologics in several leadership roles in the cervical spine group, the deformity group, and business model innovation strategies for the next ten years. In 2017, Sharp began two years commuting back and forth to Chicago, IL, working for the Advanced Surgery Division of Baxter International in both U.S.- and global-focused roles with the hemostatic and sealant portfolios. He then spent time at MicroPort Orthopedics in marketing leadership positions. In late 2021, he founded Sharp Consulting Services to continue his passion for the medical device industry working with clients in the United States, Europe, and Asia. Most recently, he has joined the team at Catalyst OrthoScience as the VP of Global Marketing. Sharp is a #girldad first and foremost and second, a noisy fan of all the Memphis area sports teams. He received a Bachelor of Science in Business Administration from the University of Memphis and a Master’s in International Business from Christian Brothers University.

Carlton Weatherby

Carlton Weatherby, VP & GM—Spine & Biologics, Medtronic
Carlton Weatherby is the vice president and general manager for the Spine & Biologics Business at Medtronic, a global leader in healthcare technology. He assumed this role in February 2021 and is responsible for working across functions and geographies worldwide to ensure alignment and execution of the business strategy, with a focus on portfolio planning, innovation acceleration, customer engagement, and value stream optimization for the $2.5 billion franchise. Prior to his current role, he was the vice president of strategic sales, responsible for leading the development and implementation of key commercial initiatives and account management strategies that accelerated revenue growth, increased profitability, and expanded market share. Weatherby joined Medtronic in 2011 as part of the Corporate Business Development group, where he was responsible for evaluating and executing strategic transactions and led the acquisition and integration of several businesses across the enterprise. His background also includes sales, strategy, and business development leadership roles at UnitedHealth Group, Regent Surgical Health, and Stanford Hospital & Clinics.

Robin Young

Robin R. Young, CEO, RRY Publications LLC/PearlDiver Technologies Inc.
Robin R. Young is the founder and CEO of RRY Publications LLC and PearlDiver Technologies Inc. After a successful 25-year career on Wall Street (Stephens Inc.; Piper, Jaffray & Hopwood; John G. Kinnard and Company), he formed RRY Publications LLC to communicate to the broader medical technology community. Through RRY Publications, Young has built a multi-channel publishing platform which serves more than 300,000 orthopedic surgeons, affiliated healthcare professionals, industry executives, and others. Over the course of his career, he has been an active and integral part of the development, analysis, and funding of several major medical technologies. He is also the author of numerous published articles, over 1,000 research reports, chapters in medical textbooks, and a half dozen published books on various medical technology, biomaterials, and investment topics. Young taught at the graduate schools of the University of Minnesota and the University of Saint Thomas in St. Paul, Minnesota. Robin and his wife live just outside of Portland, Oregon on the edge of the Willamette Valley.